ClearPoint Neuro, Inc. (CLPT) vs InfuSystems Holdings, Inc. (INFU)

ClearPoint Neuro, Inc. and InfuSystems Holdings, Inc. are both Medical Devices companies. ClearPoint Neuro, Inc. and InfuSystems Holdings, Inc. are of similar size ($294.1M and $277.2M). ClearPoint Neuro, Inc. has negative trailing earnings, so its P/E is not meaningful; InfuSystems Holdings, Inc. trades at 31.7×. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 25.9% against 2.47%. InfuSystems Holdings, Inc. has the higher net margin (5.96% vs −81.8%) and the higher return on invested capital (10.6% vs −61.3%). Across the 19 metrics below, InfuSystems Holdings, Inc. leads on 13 and ClearPoint Neuro, Inc. on 6.

Valuation

Metric CLPT INFU Medical Devices median
P/E n/m 31.74 23.22
P/S 6.47 1.87 2.34
P/B 25.39 4.52 2.33
Price to free cash flow n/m 124.73 23.72
EV/EBITDA n/m 10.80 11.54
EV/Sales 6.97 2.00 2.24
Earnings yield (13.01%) 3.15% (10.09%)
Free cash flow yield (11.64%) 0.80% (8.47%)

Profitability

Metric CLPT INFU Medical Devices median
Gross margin 62.61% 57.45% 56.01%
Operating margin (73.42%) 9.26% (15.03%)
Net margin (81.76%) 5.96% (20.40%)
Free cash flow margin (74.01%) 10.56% (7.24%)
Return on equity (226.52%) 15.03% (15.32%)
Return on assets (46.21%) 8.61% (19.72%)
Return on invested capital (61.31%) 10.55% (10.33%)

Growth

Metric CLPT INFU Medical Devices median
Revenue growth (TTM) 25.86% 2.47% 8.80%
EPS growth (last fiscal year) (28.57%) 181.82% 29.03%
Revenue growth, 5-year CAGR 23.58% 8.05% 15.47%
Net income growth, 5-year CAGR 0.00% (17.49%) 0.00%

Health

Metric CLPT INFU Medical Devices median
Debt to equity 4.66 0.35 0.07
Current ratio 4.74 2.50 2.50
Net debt to EBITDA (0.14) 0.65 0.49

Dividend

Metric CLPT INFU Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric CLPT INFU Medical Devices median
Market cap 294.06m 277.24m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack